Presents data challenging a hypothesis about a futile metabolic cycle induced by thiazolidinediones (TZD) in adipose glycerol kinase in humans. Glycerol reutilization; Reduction of nonesterified fatty acids; Absence of increased glycerol kinase expression in rosiglitazone-treated type 2 diabetics.